Abstract 63P
Background
Melatonin (MT) regulates sleep and antioxidants while interacting with our microbiota. Advances in technology allow a deeper understanding of our microbiome and its environment. Research is now focused on plant-derived molecules, including sulforaphane (SFN), known for activating antioxidant responses through the Nrf2 pathway and inhibiting NF-κB. This knowledge paves the way for new research and potential treatment strategies, highlighting the potential of plant-derived molecules.
Methods
Our study observed decreased melatonin levels in 52 cancer patients with severe dysbiosis. This group also had reduced Lactobacillus acidophilus and saccharomyces boulardii. By culturing these microorganisms and adding melatonin, we saw an enhanced expression of the myrosinase gene (TGG1), and strong antiproliferative effects on cancer cultures. Our findings highlight melatonin's potential role in modulating microorganism behavior and managing dysbiosis in cancer patients.
Results
Our study found low melatonin (MT) levels in cancer patients, linked to decreased Lactobacillus acidophilus and saccharomyces boulardii levels. MT exposure enhanced myrosinase gene expression and showed antiproliferative effects on cancer cultures. The use of NO synthase inhibitor reduced SFN yield, yet MT counteracted this effect. This emphasizes MT's potential role in SFN synthesis regulation and cancer disease initiation. Particularly, in cancer patients, decreased SFN biosynthesis due to deficiency of these microorganisms and dysbiosis may increase oxidative stress, initiating cancerous conditions.
Conclusions
This finding has implications for understanding SFN synthesis regulation by NO and H2O2. Importantly, in cancer patients with a lack of Lactobacillus acidophilus and saccharomyces boulardii and MT deficiency, there's an increased risk of oxidative stress, creating conditions conducive to cancer. Unresolved is whether MT deficiency precedes the failure of these microorganisms and myrosinase gene inhibition, or if these conditions result from deep dysbiosis leading to MT deficiency.
Editorial acknowledgement
Thanks so much of our consultants from Tbilisi State Medical University:
Professor Gaiane Simonia and Professor Nana Okrostsvaridze
Clinical trial identification
Legal entity responsible for the study
Tbilisi State Medical University and Institute for Personalized Medicine.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
20P - Effects of <italic>Apis dorsata</italic> honey on the expression of selected CYP450, pro-apoptotic, and anti-apoptotic genes during induced cytotoxicity in cyclophosphamide-treated human lung carcinoma (A549) cells
Presenter: Jose Kenneth Narag
Session: Cocktail & Poster Display session
Resources:
Abstract
21P - Hsa_circ_0009061 inhibits the progression of bladder cancer through the miR-889-3p/CPEB3 axis
Presenter: Minkang Wu
Session: Cocktail & Poster Display session
Resources:
Abstract
22P - Exploring exportin-1 as a therapeutic vulnerability in lung squamous cell carcinoma
Presenter: Vidushi Durani
Session: Cocktail & Poster Display session
Resources:
Abstract
23P - Identification of HPSE as potential novel therapeutic target for lung adenocarcinoma patients
Presenter: Samuel Doré
Session: Cocktail & Poster Display session
Resources:
Abstract
24P - High-throughput plasma proteomics profiling in early breast cancer
Presenter: Isabella Lombardo
Session: Cocktail & Poster Display session
Resources:
Abstract
25P - Immunohistochemical analysis of ROR1 and BMI-1 expression in luminal breast cancer
Presenter: Sergey Vtorushin
Session: Cocktail & Poster Display session
Resources:
Abstract
26P - Associations between cancer stem cells (CSC) markers and androgen (AR) and estrogen (ER) receptors expression in prostate cancer (PCa)
Presenter: Marina Puchinskaya
Session: Cocktail & Poster Display session
Resources:
Abstract
27P - Proteomic profiling reveals organ-specific differences in metastases and identifies potential biomarkers for recurrence risk in localized colon cancer
Presenter: Blanca García-Micó
Session: Cocktail & Poster Display session
Resources:
Abstract
28P - Collagen-activated signalling pathway is significantly hypermethylated in high-grade serous ovarian cancer (HGSOC) patients treated with platinum-containing neoadjuvant chemotherapy (NACT)
Presenter: Jose Alejandro Perez Fidalgo
Session: Cocktail & Poster Display session
Resources:
Abstract
29P - Quantitative tissue analysis reveal adenylate kinase 2 protein signatures: Therapeutic target for meningioma
Presenter: Rashmi Rana
Session: Cocktail & Poster Display session
Resources:
Abstract